Skip to main content

Supplements

Adjunctive Lipid-Lowering Strategies for Patients Needing Additional LDL-C Lowering

The Role of Non-Statin Lipid-Lowering Therapy in Older Adults with ASCVD

Minimizing the Burden of Cardiovascular Disease: A Need for Lipid-Lowering Strategies Beyond Statins

Achieving Improved Outcomes Through Partnerships Between Optometrists and Retina Specialists

Advancing Anticoagulation Safety: Focus on Factor Xa Reversal

Emerging Therapeutic Approaches to Treatment-Resistant Depression: Meeting Unmet Clinical Needs

March 2018, Supplement - Abemaciclib (Verzenio™), a Novel CDK4/6 Inhibitor, in the Treatment of Hormone Receptor–Positive, HER2-Negative Advanced Breast Cancer

A Multistakeholder Consensus on Challenges and Solutions to the Adoption of Biosimilars

Robert M. Rifkin, MD, FACP, Edward Li, PharmD, MPH, BCOP, Gillian Woollett, MA, DPhil

Practice Management

Value-Based Perspectives on the Management of Allergic Rhinitis

Eli O. Meltzer, MD, Don A. Bukstein, MD, Paul M. Hamrah, MS, PharmD, Nikkia Scott, PharmD, John A. Welz, MPH

Kevzara (Sarilumab): A Novel IL-6 Receptor Antagonist for Rheumatoid Arthritis

Page 1 of 6
Results 1 - 10 of 51